세계의 의료용 튜브 시장 : 용도별, 소재별, 구조별, 지역별 - 예측(-2030년)

The medical tubing market is projected to reach USD 18.41 billion by 2030 from USD 12.53 billion in 2025, at a CAGR of 8.0% during the forecast period. The expansion in the medical tubing market is due to rise in cases of chronic disease, including cardiovascular conditions, cancer, and respiratory conditions. Many of these illnesses demand medical equipment like catheters, infusion equipment, and ventilators that involve tubing for treatment and management effectiveness. For example, increasing prevalence of respiratory conditions such as asthma and tuberculosis has promoted demand for ventilator tubing systems. The rise in the elderly population, also more prone to chronic diseases and surgery, is another major reason. This increase in the old age population led to an uptrend in need for minimally invasive procedures with medical tubing featuring a key element in drug administration and fluid delivery systems. Moreover, companies' strategic moves, including product launches and mergers, are broadening market coverage and visibility. Finally, rigorous regulatory requirements and government spending on healthcare infrastructure are driving market growth by providing high-quality tubing products for various applications. All these factors together put the medical tubing market in line for long-term growth in the next few years.

"Rubber is the second fastest-growing material in the medical tubing market during the forecast period."

Rubber is the second fastest-growing medical tubing material because of its better flexibility, durability, and biocompatibility, which make it suitable for numerous medical applications. Natural and synthetic rubbers, including silicone, latex, and thermoplastic elastomers (TPE), provide good resistance to harsh temperatures, chemicals, and multiple sterilization cycles. This makes rubber tubing ideally suited to be used in catheters, respiratory therapy units, peristaltic pumps, and surgery drainage systems. Silicone rubber is specifically used on a large scale owing to its superior biocompatibility, for which it is considered a material of choice for implantable and long-term medical uses. In addition, rubber products have higher resilience that allows medical tubing to withstand bending and stretching without loss of integrity, hence offering enhanced patient comfort and device performance. The growing prevalence of chronic conditions, such as cardiovascular and respiratory diseases, has fueled the demand for medical devices that incorporate rubber tubing. In addition, advances in rubber formulations, including antimicrobial coatings and increased tensile strength, have contributed to its applications in critical care. With advances in healthcare innovation, rubber tubing continues to be a top contender, thus qualifying it as the second fastest-growing material in the medical tubing market.

"Braided tubing is the second fastest-growing structure in the medical tubing market during the forecast period."

Braided tubing is the second fastest-growing medical tubing structure because of its excellent combination of strength, flexibility, and versatility that can address a broad spectrum of sophisticated medical uses. Its structure, with a reinforcing braided layer commonly composed of materials such as stainless steel or nylon inserted inside polymer tubing, provides the best resistance to high pressure and kinking than its non-reinforced counterparts. This makes it most appropriate for high-performance applications such as catheters, endoscopes, and cardiovascular devices, where durability and precise fluid delivery are of the highest priority. The growing need for minimally invasive procedures, which require tubing that can navigate through intricate anatomical pathways without compromising performance, significantly enhances its application. Braided tubing can withstand sterilization processes and maintain structural integrity under stress conditions also helps in meeting the strict safety requirements of the medical sector. Rising prevalence of chronic diseases, coupled with the aging population and their requirement for advanced diagnostic and therapeutic equipment, also fuels its market growth. New braiding technology and material science enable it to be even more flexible and enable customization to fulfill particular medical needs. While single-lumen tubing may be the culprit by way of simplicity and ubiquity, the greater mechanical properties and biocompatibility of braided tubing with high-performance uses position it as a fast-rising market that responds well to shifting needs of modern healthcare.

"Catheters & cannulas is the second fastest-growing structure in the medical tubing market during the forecast period."

The catheters & cannulas market is the second fastest-growing application of the medical tubing market owing to a number of major driving factors behind its demand. As the global healthcare systems focus on minimally invasive interventions, catheters & cannulas are becoming the tools of choice, providing safer and less traumatic alternatives to conventional surgeries. These soft tubes play a vital role in uses such as cardiovascular interventions, urinary drainage, and intravenous therapy, where accuracy and patient comfort are of utmost importance. Growing prevalence of chronic illness, including cardiovascular conditions, diabetes, and renal disorders, mainly in aging communities, also catalyzes such expansion. Demand for catheterization in treatment of heart problems or urinary incontinence automatically increases demand for special tubing. Advancements in technology also are contributing factors with improved biocompatible materials, including silicone and polyurethane, improving functionality, longevity, and safety for catheters & cannulas. Besides, the move towards outpatient treatment and home healthcare increases their application in portable equipment, like infusion pumps. The segment is helped by the increasing investments in healthcare, particularly in sectors that are emerging, as enhanced infrastructure and availability of medical services increase the demand for disposable and sterile tubing.

"The Middle East and Africa (MEA) market is projected to register the second fastest growing market for medical tubing during the forecast period."

Middle East & Africa (MEA) is the second fastest-growing market for medical tubing owing to mounting healthcare investment, enhancing medical infrastructure, and rising demand for high-tech medical devices. Regional governments, specifically those of Saudi Arabia, UAE, and South Africa, are greatly investing in the modernization of healthcare, generating the demand for superior medical tubing for usage in hospitals, clinics, and diagnostic centers. The growth of healthcare facilities, coupled with the creation of medical free zones and manufacturing centers, is increasing local production and distribution of medical tubing and associated devices. The increasing incidence of chronic diseases like diabetes, cardiovascular diseases, and respiratory diseases has boosted the use of medical tubing in drug delivery systems, catheters, and respiratory devices. The increased geriatric population in the region also demands advanced medical treatment, thereby propelling the use of medical tubing-based applications. The transition towards home healthcare and wearable medical devices, including insulin pumps and oxygen therapy devices, is another key driver for market growth. Worldwide medical device companies are expanding their reach in the MEA region through collaborations, joint ventures, and establishing regional production units. All this growth increases the number of better-quality medical tubing products available and reduces dependency on imports, and consequently healthcare becomes affordable. Medical tubing technologies such as biodegradable and antimicrobial medical tubing grow more popular in MEA as healthcare professionals continue to prioritize infection control and eco-friendliness.

Extensive primary interviews were conducted to determine and verify the market size for several segments and sub-segments and the information gathered through secondary research.

The break-up of primary interviews is given below:

• By Department: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
• By Designation: C Level: 35%, Director Level: 30%, and Executives: 35%
• By Region: North America: 25%, Europe: 45%, Asia Pacific: 20%, South America: 5%, Middle East & Africa 5%

Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), Teknor Apex (US), Spectrum Plastics Group (US) Zeus Company LLC (US) among others are some of the key players in the medical tubing market.

The study includes an in-depth competitive analysis of these key players in the authentication and brand

protection market, with their company profiles, recent developments, and key market strategies.

Research Coverage

The market study covers the medical tubing market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on material, application, structure, end-use industry, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the medical tubing market.

Key Benefits of Buying the Report

The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical tubing market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (Increase in geriatric population, Increasing demand for minimally invasive medical procedures, Stringent quality standards and regulations, Advancements in extrusion technology), restraints (Limited material compatibility), opportunities (Customization and innovation in polymers and tubing structure, Increasing government expenditure for upgrading and developing healthcare infrastructure), challenges (High cost of producing and marketing medical tubing products).
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical tubing market
• Market Development: Comprehensive information about lucrative markets - the report analyses the medical tubing market across varied regions

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical tubing market

• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), Teknor Apex (US), Spectrum Plastics Group (US) Zeus Company LLC (US) among others are the top manufacturers covered in the medical tubing market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
  • 1.3.5 UNITS CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 List of key secondary sources
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 List of primary interview participants-demand and supply side
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of interviews with experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 FORECAST NUMBER CALCULATION
• 2.4 DATA TRIANGULATION
• 2.5 FACTOR ANALYSIS
• 2.6 ASSUMPTIONS
• 2.7 LIMITATIONS AND RISKS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL TUBING MARKET
• 4.2 MEDICAL TUBING MARKET, BY MATERIAL
• 4.3 MEDICAL TUBING MARKET, BY APPLICATION
• 4.4 MEDICAL TUBING MARKET, BY REGION

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing geriatric population
    • 5.2.1.2 Increasing demand for minimally invasive medical procedures
    • 5.2.1.3 Advancements in extrusion technology
    • 5.2.1.4 Stringent quality standards and regulations
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Limited material compatibility
    • 5.2.2.2 Environmental and disposal concerns
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Advancements in biocompatible and smart materials
    • 5.2.3.2 Increasing government expenditure to upgrade and develop healthcare infrastructure
  • 5.2.4 CHALLENGES
    • 5.2.4.1 High production costs and marketing complexities
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 THREAT OF NEW ENTRANTS
  • 5.3.2 THREAT OF SUBSTITUTES
  • 5.3.3 BARGAINING POWER OF SUPPLIERS
  • 5.3.4 BARGAINING POWER OF BUYERS
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.4.2 BUYING CRITERIA
• 5.5 MACROECONOMIC INDICATORS
  • 5.5.1 GLOBAL GDP TRENDS

6 INDUSTRY TRENDS

• 6.1 INTRODUCTION
• 6.2 VALUE CHAIN ANALYSIS
• 6.3 REGULATORY LANDSCAPE
  • 6.3.1 REGULATIONS
    • 6.3.1.1 North America
    • 6.3.1.2 Asia Pacific
    • 6.3.1.3 Europe
  • 6.3.2 STANDARDS
    • 6.3.2.1 ISO standard
    • 6.3.2.2 Food and drug administration (FDA)
    • 6.3.2.3 ASTM (American society for testing and materials) standards
  • 6.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 6.4 TRADE ANALYSIS
  • 6.4.1 IMPORT SCENARIO (HS CODE 3917)
  • 6.4.2 EXPORT SCENARIO (HS CODE 3917)
• 6.5 ECOSYSTEM ANALYSIS
• 6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 6.7 CASE STUDY ANALYSIS
  • 6.7.1 FREUDENBERG MEDICAL TO PROVIDE SPECIALTY BALLOON CATHETERS
  • 6.7.2 W. L. GORE & ASSOCIATES, INC. PROVIDES GORE STA-PURE PUMP TUBING
• 6.8 TECHNOLOGY ANALYSIS
  • 6.8.1 KEY TECHNOLOGIES
    • 6.8.1.1 Extrusion technology
    • 6.8.1.2 Advanced material technologies
  • 6.8.2 COMPLEMENTARY TECHNOLOGIES
    • 6.8.2.1 Smart technologies and connectivity
    • 6.8.2.2 Surface treatment and modification
• 6.9 KEY CONFERENCES AND EVENTS, 2025
• 6.10 PATENT ANALYSIS
  • 6.10.1 METHODOLOGY
  • 6.10.2 DOCUMENT TYPES
  • 6.10.3 PUBLICATION TRENDS IN LAST 11 YEARS
  • 6.10.4 INSIGHTS
  • 6.10.5 LEGAL STATUS OF PATENTS
  • 6.10.6 JURISDICTION ANALYSIS
  • 6.10.7 TOP APPLICANTS
• 6.11 IMPACT OF AI/GEN AI ON MEDICAL TUBING MARKET
• 6.12 PRICING ANALYSIS
  • 6.12.1 AVERAGE SELLING PRICE, BY REGION, 2021-2024
  • 6.12.2 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2024
  • 6.12.3 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2021-2024
• 6.13 INVESTMENT AND FUNDING SCENARIO

7 MEDICAL TUBING MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 BULK DISPOSABLE TUBING
  • 7.2.1 DEMAND FROM HOSPITALS, HOME HEALTHCARE PROVIDERS, AND EMERGENCY CARE PROVIDERS TO BOOST MARKET
  • 7.2.2 DIALYSIS TUBING
    • 7.2.2.1 Growing aging population to drive demand
  • 7.2.3 INTRAVENOUS TUBING
    • 7.2.3.1 Technological advancements to drive market
• 7.3 CATHETERS & CANNULAS
  • 7.3.1 RISING CARDIOVASCULAR DISEASES AND DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO FUEL MARKET GROWTH
  • 7.3.2 CATHETERS
    • 7.3.2.1 Increase in chronic diseases contributing to significant demand
    • 7.3.2.2 Cardiovascular catheters
      • 7.3.2.2.1 Growing elderly population and high incidence of cardiovascular diseases to propel market
    • 7.3.2.3 IV catheters
      • 7.3.2.3.1 Demand for direct delivery of medication and nutrients into bloodstream to fuel growth
    • 7.3.2.4 Urinary catheters
      • 7.3.2.4.1 Rising incidences of urinary tract infections and growing need for advanced technologies to drive demand
  • 7.3.3 CANNULAS
    • 7.3.3.1 Evolving healthcare sector and stringent regulatory requirements to support market growth
• 7.4 DRUG DELIVERY SYSTEMS
  • 7.4.1 PRECISE DRUG DELIVERY TO TARGET SITES TO DRIVE DEMAND
  • 7.4.2 NASOGASTRIC
    • 7.4.2.1 Need for enteral feeding and drainage to fuel demand
  • 7.4.3 NEBULIZERS
    • 7.4.3.1 Conversion of liquid medications to mists for inhalation to drive market
• 7.5 OTHER APPLICATIONS
  • 7.5.1 PERISTALTIC PUMP TUBING
    • 7.5.1.1 Wide demand for minimizing contamination to boost market
  • 7.5.2 GAS SUPPLY TUBING
    • 7.5.2.1 Increasing minimally invasive surgeries to support market growth
  • 7.5.3 SMOKE EVACUATION TUBING
    • 7.5.3.1 Popularity of cosmetic procedures and medical tourism to drive market

8 MEDICAL TUBING MARKET, BY MATERIAL

• 8.1 INTRODUCTION
• 8.2 PLASTICS
  • 8.2.1 BIOCOMPATIBILITY, CHEMICAL STABILITY, AND COST-EFFECTIVENESS TO BOOST MARKET
  • 8.2.2 POLYVINYL CHLORIDE (PVC)
  • 8.2.3 POLYOLEFIN
    • 8.2.3.1 Polyethylene (PE)
    • 8.2.3.2 Polypropylene (PP)
  • 8.2.4 POLYAMIDE
  • 8.2.5 POLYTETRAFLUOROETHYLENE (PTFE)
  • 8.2.6 POLYETHER ETHER KETONE (PEEK)
  • 8.2.7 POLYCARBONATE (PC)
• 8.3 RUBBERS
  • 8.3.1 SIGNIFICANT DURABILITY AND RESILIENCE TO DRIVE DEMAND
  • 8.3.2 THERMOPLASTIC ELASTOMER (TPE)
  • 8.3.3 THERMOPLASTIC POLYURETHANE (TPU)
  • 8.3.4 SILICONE
  • 8.3.5 POLYURETHANE (PU)
  • 8.3.6 ETHYLENE PROPYLENE DIENE MONOMER (EPDM)
  • 8.3.7 LATEX
• 8.4 SPECIALTY POLYMERS
  • 8.4.1 DEMAND FOR SPECIALIZED TREATMENT TO BOOST MARKET
  • 8.4.2 BIOABSORBABLE POLYMERS
  • 8.4.3 ETHYLENE VINYL ACETATE (EVA)
• 8.5 OTHER MATERIALS

9 MEDICAL TUBING MARKET, BY STRUCTURE

• 9.1 INTRODUCTION
• 9.2 SINGLE-LUMEN
  • 9.2.1 DEMAND FOR ADMINISTRATION OF FLUIDS AND MEDICATION, AIRWAY MANAGEMENT, AND PATIENT NUTRITION TO DRIVE MARKET
• 9.3 CO-EXTRUDED
  • 9.3.1 DURABILITY, LUBRICITY, OPACITY, RADIOPACITY, AND TENSILE STRENGTH TO BOOST MARKET
• 9.4 MULTI-LUMEN
  • 9.4.1 NON-TOXICITY, BIOCOMPATIBILITY, AND INERTNESS TO FUEL MARKET DEMAND
• 9.5 TAPERED OR BUMP TUBING
  • 9.5.1 ENHANCED FUNCTIONALITIES IN CVC, PICC, AND DRUG DELIVERY CATHETERS TO DRIVE MARKET
• 9.6 BRAIDED TUBING
  • 9.6.1 GOOD STRENGTH, STEERABILITY, AND PRESSURE RESISTANCE TO PROPEL MARKET

10 MEDICAL TUBING MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 US
    • 10.2.1.1 High disposable income and strong healthcare infrastructure to drive market
  • 10.2.2 CANADA
    • 10.2.2.1 Aging population and increasing healthcare expenditure to support market growth
  • 10.2.3 MEXICO
    • 10.2.3.1 High investments and low manufacturing costs to fuel demand
• 10.3 EUROPE
  • 10.3.1 GERMANY
    • 10.3.1.1 Advanced medical facilities and R&D investments to propel market
  • 10.3.2 FRANCE
    • 10.3.2.1 Rising elderly population to fuel market growth
  • 10.3.3 UK
    • 10.3.3.1 Innovation, technological advancements, and investments to drive market
  • 10.3.4 SPAIN
    • 10.3.4.1 Growing aging population and improvements in healthcare system to increase consumption
  • 10.3.5 ITALY
    • 10.3.5.1 Growing geriatric population and strong focus on research and innovation to drive market
  • 10.3.6 NETHERLANDS
    • 10.3.6.1 Rising homecare treatment to increase demand
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 CHINA
    • 10.4.1.1 Investments in manufacturing medical devices to support market
  • 10.4.2 JAPAN
    • 10.4.2.1 Implementation of AI and big data technologies in healthcare industry to increase demand
  • 10.4.3 INDIA
    • 10.4.3.1 Government initiatives, high purchasing power, and rising manufacturing output to fuel demand
  • 10.4.4 SOUTH KOREA
    • 10.4.4.1 Medical tourism to lead to market growth
  • 10.4.5 REST OF ASIA PACIFIC
• 10.5 MIDDLE EAST & AFRICA
  • 10.5.1 GCC COUNTRIES
    • 10.5.1.1 Saudi Arabia
      • 10.5.1.1.1 Government initiatives to support market growth
    • 10.5.1.2 UAE
      • 10.5.1.2.1 Government funding and rapidly developing private health sector to drive market
  • 10.5.2 SOUTH AFRICA
    • 10.5.2.1 Increasing awareness, testing, and treatment programs to drive market
  • 10.5.3 EGYPT
    • 10.5.3.1 Technological advancements and improving healthcare sector to fuel demand
  • 10.5.4 REST OF MIDDLE EAST & AFRICA
• 10.6 SOUTH AMERICA
  • 10.6.1 BRAZIL
    • 10.6.1.1 Growing healthcare system to increase consumption
  • 10.6.2 ARGENTINA
    • 10.6.2.1 Rising prevalence of chronic diseases, aging population, and advances in medical sector to drive market
  • 10.6.3 REST OF SOUTH AMERICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2025
• 11.3 REVENUE ANALYSIS, 2024
• 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.4.1 SAINT-GOBAIN
  • 11.4.2 FREUDENBERG MEDICAL
  • 11.4.3 THE LUBRIZOL CORPORATION
  • 11.4.4 W. L. GORE & ASSOCIATES, INC.
  • 11.4.5 TE CONNECTIVITY
• 11.5 COMPANY VALUATION AND FINANCIAL METRICS
• 11.6 BRAND COMPARISON
  • 11.6.1 MEDICAL TUBING MARKET: BRAND COMPARISON
  • 11.6.2 BIO-SIL TUBING
  • 11.6.3 HELIXFLEX
  • 11.6.4 ISOPLAST ETPU MEDICAL TUBING
  • 11.6.5 GORE STA-PURE PUMP TUBING SERIES PFL
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.7.5.1 Company footprint
    • 11.7.5.2 Region footprint
    • 11.7.5.3 Structure footprint
    • 11.7.5.4 Material footprint
    • 11.7.5.5 Application footprint
• 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 RESPONSIVE COMPANIES
  • 11.8.3 DYNAMIC COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 11.8.5.1 Detailed list of key startups/SMEs
    • 11.8.5.2 Competitive benchmarking of startups/SMEs
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES
  • 11.9.2 DEALS
  • 11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 SAINT-GOBAIN
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products/Solutions/Services offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Right to win
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 FREUDENBERG MEDICAL
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products/Solutions/Services offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches
      • 12.1.2.3.2 Deals
      • 12.1.2.3.3 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Right to win
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 THE LUBRIZOL CORPORATION
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products/Solutions/Services offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Deals
      • 12.1.3.3.2 Expansions
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Right to win
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 W. L. GORE & ASSOCIATES, INC.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products/Solutions/Services offered
    • 12.1.4.3 MnM view
      • 12.1.4.3.1 Right to win
      • 12.1.4.3.2 Strategic choices
      • 12.1.4.3.3 Weaknesses and competitive threats
  • 12.1.5 NORDSON CORPORATION
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products/Solutions/Services offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Right to win
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses and competitive threats
  • 12.1.6 TE CONNECTIVITY
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products/Solutions/Services offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches
    • 12.1.6.4 MnM view
  • 12.1.7 ELKEM ASA
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products/Solutions/Services offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Deals
      • 12.1.7.3.2 Expansions
    • 12.1.7.4 MnM view
  • 12.1.8 TRELLEBORG AB
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products/Solutions/Services offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Deals
      • 12.1.8.3.2 Other developments
    • 12.1.8.4 MnM view
  • 12.1.9 RAUMEDIC AG
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products/Solutions/Services offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches
      • 12.1.9.3.2 Deals
      • 12.1.9.3.3 Expansions
    • 12.1.9.4 MnM view
  • 12.1.10 TEKNOR APEX
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products/Solutions/Services offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product launches
      • 12.1.10.3.2 Deals
    • 12.1.10.4 MnM view
  • 12.1.11 SPECTRUM PLASTICS GROUP
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products/Solutions/Services offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Deals
      • 12.1.11.3.2 Expansions
    • 12.1.11.4 MnM view
  • 12.1.12 ZEUS COMPANY LLC
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products/Solutions/Services offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Product launches
      • 12.1.12.3.2 Expansions
    • 12.1.12.4 MnM view
• 12.2 OTHER PLAYERS
  • 12.2.1 ATAG SPA
  • 12.2.2 DAVIS STANDARD
  • 12.2.3 FBK MEDICAL TUBING
  • 12.2.4 PROTERIAL CABLE AMERICA, INC.
  • 12.2.5 ICO RALLY
  • 12.2.6 ICU MEDICAL, INC.
  • 12.2.7 KRATON CORPORATION
  • 12.2.8 MICROLUMEN INC.
  • 12.2.9 MDC INDUSTRIES
  • 12.2.10 NEWAGE INDUSTRIES
  • 12.2.11 OPTINOVA
  • 12.2.12 PARKER HANNIFIN CORP.
  • 12.2.13 TEEL PLASTICS
  • 12.2.14 VESTA INC.
  • 12.2.15 SMOOTH-BOR PLASTICS

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS